Dr. Jeff Schwegman
J. Jeff Schwegman, Ph.D. is currently the founder and chief executive ofcer of AB BioTechnologies where he develops
formulations, lyophilization cycles, determines residual moisture by Karl Fischer, and provides thermal characterization studies
including freeze-dry microscopy and DSC. Additionally, Dr. Schwegman specializes in speaking and consulting in parenteral
pre-formulation, formulation, analytical, and lyophilization of both small molecules and large biomolecules. Dr. Schwegman
received his BS in Biochemistry from Indiana University in 1992 and began working at Cook Imaging in Bloomington
Indiana, where he gained experience in analytical, formulation and process development. In 1999 he began graduate study
in the Department of Industrial and Physical Pharmacy at Purdue University under the direction of Dr. Steve Nail, where his
focus of research involved studying changes in the physical structure of biological molecules during lyophilization. Dr.
Schwegman received his Ph.D. from Purdue University in 2003, and returned to Bloomington where he worked at Baxter
Pharmaceutical Solutions as a Research Scientist in the Pharmaceutical Development group. He specializes in speaking and
consulting in parenteral pre-formulation, formulation, analytical, and lyophilization of both small molecules and large
biomolecules. He has also been an active member of AAPS since 2001.